Divergent Isoprenoid Biosynthesis Pathways in <italic toggle="yes">Staphylococcus</italic> Species Constitute a Drug Target for Treating Infections in Companion Animals
ABSTRACT Staphylococcus species are a leading cause of skin and soft tissue infections in humans and animals, and the antibiotics used to treat these infections are often the same. Methicillin- and multidrug-resistant staphylococcal infections are becoming more common in human and veterinary medicin...
Guardado en:
Autores principales: | Ana M. Misic, Christine L. Cain, Daniel O. Morris, Shelley C. Rankin, Daniel P. Beiting |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c6126e08cd1341dbbf2c5dccf6b05a8e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Metabolite Repair Enzyme Phosphoglycolate Phosphatase Regulates Central Carbon Metabolism and Fosmidomycin Sensitivity in <named-content content-type="genus-species">Plasmodium falciparum</named-content>
por: Laure Dumont, et al.
Publicado: (2019) -
Suppression of Drug Resistance Reveals a Genetic Mechanism of Metabolic Plasticity in Malaria Parasites
por: Ann M. Guggisberg, et al.
Publicado: (2018) -
Systems-Level Analysis of Oxygen Exposure in <italic toggle="yes">Zymomonas mobilis</italic>: Implications for Isoprenoid Production
por: Julia I. Martien, et al.
Publicado: (2019) -
A Metabolic Dependency for Host Isoprenoids in the Obligate Intracellular Pathogen <named-content content-type="genus-species">Rickettsia parkeri</named-content> Underlies a Sensitivity to the Statin Class of Host-Targeted Therapeutics
por: Vida Ahyong, et al.
Publicado: (2019) -
Diversifying Isoprenoid Platforms via Atypical Carbon Substrates and Non-model Microorganisms
por: David N. Carruthers, et al.
Publicado: (2021)